Mgic Investment Corp (MTG) 6.23 $MTG MGIC Investment

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mgic Investment Corp (MTG) 6.23 $MTG

MGIC Investment Corporation Releases Monthly Operating Statistics
PR Newswire - Wed Jun 08, 5:45AM CDT
MGIC Investment Corporation (NYSE: MTG) today issued a May 2016 Operational Summary of the primary mortgage insurance of its insurance subsidiaries. The summary is also available on the company's website at http://mtg.mgic.com, under Investor Information, Press Releases.
MTG: 6.23 (-0.18)

After Yesterday's Rally of 1.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri May 27, 3:25PM CDT
MGIC Investment (NYSE:MTG) traded in a range yesterday that spanned from a low of $6.96 to a high of $7.06. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $6.99 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MTG: 6.23 (-0.18)

MGIC CEO to Participate in KBW Mortgage Finance Conference
PR Newswire - Tue May 24, 3:44PM CDT
MGIC Investment Corporation (NYSE: MTG) announced today that Patrick Sinks, Chief Executive Officer, will be discussing the Private Mortgage Insurance industry at the Keefe, Bruyette & Woods 2016 Mortgage Finance Conference. The discussion is scheduled to begin at 10:40 a.m. Eastern time on June 1, 2016, and the conference is being held at the Westin Grand Central hotel in New York City.
MTG: 6.23 (-0.18)

After Yesterday's Decline of 1.79%, MGIC Investment Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 13, 3:37PM CDT
MGIC Investment (NYSE:MTG) traded in a range yesterday that spanned from a low of $6.55 to a high of $6.75. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $6.67 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MTG: 6.23 (-0.18)

Cigna (CI) Beats on Q1 Earnings & Revenues, Revises View
Zacks Equity Research - Zacks Investment Research - Fri May 06, 10:06AM CDT
Cigna Corp. (CI) reported first-quarter 2016 operating net earnings of $2.32 per share that comfortably beat the Zacks Consensus Estimate of $2.17 by 6.9%.
CI: 126.50 (-1.58), RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), MTG: 6.23 (-0.18)

MetLife (MET) Misses Q1 Earnings and Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:47AM CDT
MetLife, Inc.'s (MET) first-quarter 2016 earnings of $1.31 per share missed the Zacks Consensus Estimate of $1.39 by 5.8%.
RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), MET: 42.90 (-0.19), MTG: 6.23 (-0.18)

Prudential (PRU) Q1 Earnings Miss, Down Y/Y on Low Revenues
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:16AM CDT
Prudential Financial, Inc. (PRU) reported first-quarter 2016 after tax adjusted operating income of $2.18 per share that missed the Zacks Consensus Estimate by 8.4%.
RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), PRU: 73.12 (-0.42), MTG: 6.23 (-0.18)

American International (AIG) Q1 Earnings Miss, Plunge Y/Y
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:19AM CDT
American International Group Inc. (AIG) reported first-quarter 2016 operating income of 65 cents per share that missed the Zacks Consensus Estimate of 99 cents by 34.3%. Earnings also plunged 46.7% year on year.
CNO: 18.73 (-0.38), AIG: 54.40 (-0.59), MTG: 6.23 (-0.18), GNW: 3.27 (-0.10)

Genworth (GNW) Q1 Earnings Beat Estimates, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 10:04AM CDT
Genworth Financial, Inc. (GNW) reported first-quarter 2016 net operating income of 21 cents per share, which handily beat the Zacks Consensus Estimate of 14 cents per share by 50%.
RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), MTG: 6.23 (-0.18), GNW: 3.27 (-0.10)

MGIC Investment Corporation Shareholders Elect Directors and Approve Other Actions
PR Newswire - Thu Apr 28, 3:30PM CDT
MGIC Investment Corporation's (NYSE: MTG) shareholders have elected the company's current eleven directors to an additional one-year term.
MTG: 6.23 (-0.18)

CNO Financial (CNO) Q1 Earnings Miss, Revenues Surpass
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 10:24AM CDT
CNO Financial Group, Inc.'s (CNO) first-quarter 2016 net operating earnings of 27 cents per share missed the Zacks Consensus Estimate by 15.6%.
RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), CNO: 18.73 (-0.38), MTG: 6.23 (-0.18)

Radian Group (RDN) Q1 Earnings, Revenues Beat Estimates
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 4:50AM CDT
Radian Group Inc. (RDN) reported first-quarter 2016 operating income of 37 cents per share, beating the Zacks Consensus Estimate by 23% and improving 5.7% year over year.
RDN: 11.05 (-0.30), AIZ: 84.19 (-0.58), CNO: 18.73 (-0.38), MTG: 6.23 (-0.18)

Downgrade Alert for MGIC Investment (MTG)
Comtex SmarTrend(R) - Thu Apr 21, 3:47AM CDT
MGIC Investment (NYSE:MTG) was downgraded from Buy to Neutral at Compass Point today. The stock closed yesterday at $7.44 on volume of 9.7 million shares, above average daily volume of 3.9 million. There is potential upside of 63.7% for shares of MGIC Investment based on a current price of $7.44 and an average consensus analyst price target of $12.18. The stock should hit resistance at its 200-day moving average (MA) of $8.93, as well as support at its 50-day MA of $7.28.
MTG: 6.23 (-0.18)

MGIC Investment (MTG) Lags Q1 Earnings: Stock to Suffer?
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:04AM CDT
MGIC Investment Corporation (MTG) reported first-quarter 2016 adjusted net income per share of 19 cents, which missed the Zacks Consensus Estimate of 23 cents by 17.4%.
MET: 42.90 (-0.19), MTG: 6.23 (-0.18)

MGIC Investment Corporation Reports First Quarter 2016 Results
PR Newswire - Tue Apr 19, 5:45AM CDT
MGIC Investment Corporation (NYSE:MTG) today reported net income for the quarter ended March 31, 2016 of $69.2 million, compared with a net income of $133.1 million for the same quarter a year ago. Diluted net income per share was $0.17 for the quarter ending March 31, 2016, compared to diluted net income per share of $0.32 for the same quarter a year ago. As explained below there was activity in both periods that impacted the comparability of results on a year over year basis.
MTG: 6.23 (-0.18)

Stock Market News for April 14, 2016
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 9:10AM CDT
Benchmarks finished in the green on Wednesday following a rally in financial stocks.
NYCB: 15.06 (-0.32), JPM: 63.27 (-0.57), PACW: 39.83 (-0.59), USB: 41.68 (-0.28), C: 43.16 (-0.74), SIVB: 102.40 (-1.37), MTB: 117.69 (+0.14), WFC: 47.97 (-0.37), MTG: 6.23 (-0.18), BRK.B: 140.94 (-0.82), CMA: 43.45 (-0.70)

MGIC Investment Corporation Schedules 1st Quarter 2016 Earnings Call and Releases Monthly Operating Statistics
PR Newswire - Fri Apr 08, 5:45AM CDT
MGIC Investment Corporation (NYSE: MTG) has announced plans to release its 1st quarter 2016 financial results before the market opens on Tuesday, April 19, 2016. A conference call/webcast has been scheduled for 10:00 a.m. Eastern Time to discuss the Company's results for the quarter ended March 31, 2016.
MTG: 6.23 (-0.18)

MGIC Investment Poised for Growth Amid Low Premium Rates
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 11:20AM CDT
On Mar 24, 2016, we issued an updated research report on MGIC Investment Corp. (MTG).
HALL: 10.33 (-0.16), MTG: 6.23 (-0.18), MKL: 930.19 (-6.79)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 197

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobility Direct's Inspiring Journey in Supporting the Disabled

Updated Category News Views 123

Empowering Mobility for a Decade Mobility Direct has reached a remarkable milestone, celebrating ten years of dedicated service to individuals facing mobility challenges. The company, based in Florida, has profoundly impacted the lives of many by providing free mobility scooters to those in need. With each scooter given, they challenge the common assumption that mobility...

Continue Reading
GARDANT GLOBAL Teams Up with GovConRx for Enhanced Services

Updated Category News Views 143

GARDANT GLOBAL Forms Strategic Alliance with GovConRx GARDANT GLOBAL is thrilled to share exciting news about its latest partnership with GovConRx. This collaboration is set to transform the landscape of contract performance management for government contractors. GovConRx, well-known for its expertise in enhancing CPARS ratings, will significantly augment GARDANT's...

Continue Reading
Text Request and Commify Join Forces to Enhance Messaging Solutions

Updated Category News Views 72

Text Request and Commify Join Forces to Enhance Messaging Solutions Text Request, a leader in the business text messaging domain, has recently announced an exciting new chapter following its acquisition by the U.K.-based Commify. This strategic move is aimed at expanding its reach within the U.S. market while maintaining its operational base in Chattanooga. Growth Journey...

Continue Reading
Agenus Investors Alerted on Class Action Lawsuit Developments

Updated Category News Views 64

Levi & Korsinsky Notifies Investors of Class Action for Agenus Inc. Levi & Korsinsky, LLP is reaching out to investors in Agenus Inc. (NASDAQ: AGEN) regarding a significant class action lawsuit that may impact those financially affected by the company's alleged misrepresentations. This development is crucial for stakeholders who have invested in Agenus during the...

Continue Reading
Savvas Unveils Innovative Science Curriculum for Students

Updated Category News Views 369

Introducing Experience Science for Grades K-8 In a groundbreaking initiative, Savvas Learning Company has launched Experience Science, an all-new program curated specifically for students in grades K-8. This innovative curriculum aims to engage young learners in scientific concepts, placing significant emphasis on hands-on experiences driven by real-world phenomena....

Continue Reading